Abstract

KSHV is etiologically associated with Kaposi's sarcoma (KS), an angioproliferative endothelial cell malignancy. Macropinocytosis is the predominant mode of in vitro entry of KSHV into its natural target cells, human dermal microvascular endothelial (HMVEC-d) cells. Although macropinocytosis is known to be a major route of entry for many viruses, the molecule(s) involved in the recruitment and integration of signaling early during macropinosome formation is less well studied. Here we demonstrate that tyrosine phosphorylation of the adaptor protein c-Cbl is required for KSHV induced membrane blebbing and macropinocytosis. KSHV induced the tyrosine phosphorylation of c-Cbl as early as 1 min post-infection and was recruited to the sites of bleb formation. Infection also led to an increase in the interaction of c-Cbl with PI3-K p85 in a time dependent manner. c-Cbl shRNA decreased the formation of KSHV induced membrane blebs and macropinocytosis as well as virus entry. Immunoprecipitation of c-Cbl followed by mass spectrometry identified the interaction of c-Cbl with a novel molecular partner, non-muscle myosin heavy chain IIA (myosin IIA), in bleb associated macropinocytosis. Phosphorylated c-Cbl colocalized with phospho-myosin light chain II in the interior of blebs of infected cells and this interaction was abolished by c-Cbl shRNA. Studies with the myosin II inhibitor blebbistatin demonstrated that myosin IIA is a biologically significant component of the c-Cbl signaling pathway and c-Cbl plays a new role in the recruitment of myosin IIA to the blebs during KSHV infection. Myosin II associates with actin in KSHV induced blebs and the absence of actin and myosin ubiquitination in c-Cbl ShRNA cells suggested that c-Cbl is also responsible for the ubiquitination of these proteins in the infected cells. This is the first study demonstrating the role of c-Cbl in viral entry as well as macropinocytosis, and provides the evidence that a signaling complex containing c-Cbl and myosin IIA plays a crucial role in blebbing and macropinocytosis during viral infection and suggests that targeting c-Cbl could lead to a block in KSHV infection.

Highlights

  • KSHV is etiologically associated with Kaposi’s sarcoma (KS), the most common AIDS related malignancy, as well as with two lymphoproliferative diseases, primary effusion lymphoma (PEL) and multicentric Castleman’s disease [1,2]

  • The first key step in KSHV infection is its initial contact with target cells and entry

  • While it is known that KSHV uses macropinocytosis for its infectious entry into its natural target cells, HMVEC-d cells, we know little about the molecule(s) involved in this event

Read more

Summary

Introduction

KSHV is etiologically associated with Kaposi’s sarcoma (KS), the most common AIDS related malignancy, as well as with two lymphoproliferative diseases, primary effusion lymphoma (PEL) and multicentric Castleman’s disease [1,2]. KSHV infects a variety of target cells both in vivo and in vitro. KSHV utilizes different modes of endocytosis to enter different target cells in vitro [3]. KSHV enters human foreskin fibroblasts (HFF) via clathrin mediated endocytosis and enters HMVEC-d cells via macropinocytosis [3,4,5]. During the early stages of infection of HMVEC-d cells, KSHV forms a multi-molecular complex with host cell heparan sulfate, integrins (a3b1, aVb3 and aVb5) and transporter protein xCT with the subsequent induction of overlapping signal cascades [3]. KSHV activates FAK, Src, PI3-K, Rho-GTPases and cytoskeleton rearrangement which are all critical for entry of virus [6,7,8,9]. KSHV activates other downstream molecules such as PKC-f, MEK, ERK1/2 and NFkB which are essential for viral gene expression [6,7,8,9]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call